NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Inso Biosciences

Inso Biosciences

Private
Ithaca, New YorkHealthcare & Life Scienceshttps://inso.bio/

Last Round

Grant

Jun 24, 2026

Total Funding Raised

$5.91M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Inso Biosciences is a biotechnology company that develops a cell sample preparation platform designed for genomic analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

microfluidicsDNA extractionsample preparationgenomicslab automationbiotech equipmentmulti-omicslong-read sequencingmicropillar technologybenchtop instrumentrazor-and-bladelife sciences toolsDNA purificationlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inso Biosciences Comparables

Compare Inso Biosciences with similar companies based on industry and business-model similarity.

Inso Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MicroPure Genomics Inc.
88%
Sage Science
74%
SIRION Biotech
73%

Inso Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 24, 2026
Seed RoundApr 10, 2026
AcceleratorJun 10, 2025
GrantJul 1, 2023
GrantNov 8, 2022
Grant
Sep 19, 2022

Key People

Founding team and executive leadership

Adam Bisogni

Co-Founder, Chief Scientific Officer

Founding Team

Harvey Tian

CEO Co-founder

Founding Team

Inso Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    $750K raised in Seed Round.

  • Sep 19, 2022

    $400K grant received from Empire State Development and National Cancer Institute.

Inso Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inso Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inso Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersIthaca, New York
Employee Range4
Year Founded2018
Last FundingJun 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.